GNAS and invasive carcinoma: Thus, Wu and coworkers reported the mutation of the oncogene GNAS occurring in about 66% of IPMNs: importantly, in the large majority of IPMNs progressing to PDAs with GNAS mutations, the mutation of this gene was observed also at the level of the invasive carcinoma [27].